Benjamin F. Edwards & Company, Inc. Haleon PLC Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.51 Billion
- Q1 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 42,359 shares of HLN stock, worth $358,357. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,359
Previous 27,382
54.7%
Holding current value
$358,357
Previous $225,000
60.0%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HLN
# of Institutions
637Shares Held
425MCall Options Held
82KPut Options Held
27.3K-
Dodge & Cox San Francisco, CA177MShares$1.5 Billion0.92% of portfolio
-
Clearbridge Investments, LLC New York, NY38.4MShares$325 Million0.27% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14.4MShares$122 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA13.4MShares$113 Million0.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il13.2MShares$111 Million0.02% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $39.1B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...